However, it is still unclear whether this disease mechanism is relevant in the setting of normal kidney function, because evidence from clinical studies in XLH patients and mouse models of XLH suggests that chronic FGF23 excess does not invariably cause LV hypertrophy [15,16,17,18]. This evidence concerns the gene FGF23 and X-linked hypophosphatemia.